FDA Approves Lybrel, First Low Dose Combination Oral Contraceptive Offering Women the Opportunity to Be Period-Free ... (RedNova)
COLLEGEVILLE, Pa., May 22 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth , announced today that the U.S.

Advancis Pharmaceutical Announces FDA Acceptance of Amoxicillin PULSYS NDA (PR Newswire via Yahoo! Finance)
Advancis Pharmaceutical Corporation , a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that the Company's once-daily Amoxicillin PULSYS New Drug Application has been accepted for filing by the U.S.

FDA Approves Lybrel, First Low Dose Combination Oral Contraceptive Offering Women the Opportunity to Be Period-Free ... (PR Newswire via Yahoo! Finance)
Wyeth Pharmaceuticals, a division of Wyeth , announced today that the U.S. Food and Drug Administration has approved the oral contraceptive Lybrel tablets for the prevention of pregnancy in women who elect to use oral contraceptives and who have no known contraindications for this method of contraception.